Anyone else dealing with paying $300 per month out of from a cost perspective?
I have been paying $280/month and I am trying to get insurance to cover it.
Share what you are paying and what you are getting — transparency helps everyone.
Anyone else dealing with paying $300 per month out of from a cost perspective?
I have been paying $280/month and I am trying to get insurance to cover it.
Share what you are paying and what you are getting — transparency helps everyone.
nick_newbie's experience with Paying $300 per month out resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.
The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 48 lbs in 13 months.
One thing I would add that nick_newbie did not mention: the relationship with food fundamentally changed.
Thanks for sharing this, nick_newbie. A few questions about your Paying $300 per experience:
I am in a similar boat and trying to learn from others' experiences before my next appointment.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemOP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Paying $300 per month out.
To answer BariatricNurseD: yes, I am on compounded sema from a 503B pharmacy.
Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Relevant to Paying $300 per month out of — here is my latest bloodwork comparison:
Key improvements: A1C 8.4% → 5.5%, triglycerides 221 → 91 mg/dL, hsCRP 8.0 → 0.9 mg/L. All on tirzepatide for 13 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.